Olympus Corp CEO Resigns Following Allegations
Olympus Corp, the renowned Japanese endoscope manufacturer, announced on Monday that Chief Executive Officer Stefan Kaufmann has resigned after allegations surfaced regarding his purchase of illegal drugs. This development has caused a 6% decline in the company's shares, marking the steepest drop in nearly three months.
Kaufmann, a German national, took over the CEO role in April 2023 intending to enhance Olympus's medical equipment division. He succeeded Yasuo Takeuchi, who had successfully navigated the company through extensive asset sales during his tenure.
In a company statement, Olympus disclosed that upon receiving the allegations against Kaufmann, it promptly consulted with external legal counsel and launched an investigation. The investigation's findings led the Board of Directors to unanimously conclude that Kaufmann likely engaged in behavior contrary to the company's global code of conduct and core values.
Kaufmann, 56, was asked to resign and complied with the request. As Olympus grapples with this latest scandal, Yasuo Takeuchi will temporarily reassume the CEO role.
The impact of Kaufmann's departure was evident in the stock market, as Olympus shares have seen a notable increase of 35% over the past year, outperforming the Nikkei 225 index, which rose by 24%.
This incident is not Olympus's first encounter with controversy; thirteen years ago, former CEO Michael Woodford exposed significant accounting fraud involving inflated acquisition costs to conceal financial losses. Woodford's subsequent firing sparked a turbulent battle for control of the company.


RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 



